Skip to content

AFX Endovascular AAA System BA22-90/I20-30Recalls & reported problems

Endologix LLC · Class 3 · Implant

All models of AFX Endovascular AAA System (48)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00818009012272), received between Oct 13, 2017 and Nov 21, 2018 — classified as 2 injuries.

The most frequently reported specific device problem is “Deformation Due to Compressive Stress” (1 report).

16 other recalls cover devices cleared under the same FDA submission (P040002); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Deformation Due to Compressive Stress1
  • Detachment Of Device Component1
  • Difficult to Advance1
  • Failure To Adhere Or Bond1
  • Hole In Material1
  • Leak/Splash1
  • Off-Label Use1
  • Stretched1

Patient problems

  • Failure of Implant2
  • Aneurysm1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 21, 2018Off-Label Use; Difficult to Advance; Off-Label Use; Difficult to Advance

    THE PATIENT WAS INITIALLY TREATED WITH THE AFX ABDOMINAL AORTIC ANEURYSM STENT. APPROXIMATELY THREE (3) YEARS POST INITIAL PROCEDURE, A TYPE IB ENDOLEAK WAS DETECTED BY CT. A RE-INTERVENTION WAS PERFORMED ON (B)(6) 2018 WHERE AN AFX LIMB EXTENSION WAS IMPLANTED TO EXTEND THE DISTAL SEAL. THE PATIENT DID WILL INTRA- AND POST-OPERATIVELY AND THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.

    Patient problems: Failure of Implant

    MAUDE report 8097924 ↗
  • InjuryOct 13, 2017Failure To Adhere Or Bond; Detachment Of Device Component; Hole In Material; Leak/Splash; Stretched; Deformation Due to Compressive Stress; Failure To Adhere Or Bond; Detachment Of Device Component; Hole In Material; Leak/Splash; Stretched; Deformation Due to Compressive Stress

    PATIENT WAS INITIALLY IMPLANTED IN 2015 WITH AND AFX BIFURCATED AND SUPRARENAL STENT. APPROXIMATELY TWO YEARS POST IMPLANT ON (B)(6) 2017, DURING AN ANNUAL FOLLOW UP, IT WAS DISCOVERED THAT THE PATIENT HAD AND ENDOLEAK TYPE 3A WITH COMPONENT SEPARATION. ON (B)(6) 2017, THE PATIENT UNDERWENT AN INTERVENTION AND THE PHYSICIAN ELECTED TO IMPLANT THE PATIENT WITH A BIFURCATED AND INFRARENAL EXTENSION TO RESOLVE THE LEAK. THE PATIENT WAS REPORTED TO BE DOING WELL POST PROCEDURE.

    Patient problems: Aneurysm; Failure of Implant

    MAUDE report 6947888 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P040002. One submission often covers many models, so check the product and lot details in each record.

  • Z-1048-2017 · Jan 4, 2017 · Terminated
    AFX Endovascular AAA System Item Number Item Description F0070305 A2525/C75 V F0070308 A2828/C75 V F0070312 A3434/C
  • Z-1049-2017 · Jan 4, 2017 · Terminated
    AFX2 Endovascular AAA System Item No. Item Description F00820-01 BEA28-120/I20-40 F00820-02 BEA28-100/I20-40 F00820-03 BEA28-80/I20-40 F00820-06 BEA28-120/I16-40 F00820-07 B
  • Z-1035-2017 · Dec 27, 2016 · Terminated
    AFX Endovascular AAA System, Endoleak Type IIIA
  • Z-1039-2017 · Dec 27, 2016 · Terminated
    AFX Endovascular AAA System, Endoleak Type: IIIB Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
  • Z-1047-2017 · Dec 27, 2016 · Terminated
    AFX Endovascular AAA System, Endoleak Type IIIA Product Usage: The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoili
  • Z-1054-2017 · Dec 27, 2016 · Terminated
    AFX Endovascular AAA System, Endoleak Type IIIB Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
  • Z-1038-2017 · Dec 27, 2016 · Terminated
    AFX Endovascular AAA System, Endoleak Type IIIB; The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (A
  • Z-1037-2017 · Dec 27, 2016 · Terminated
    AFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
  • Z-0595-06 · Dec 14, 2005 · Terminated
    Powerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-140BL
  • Z-0592-06 · Dec 14, 2005 · Terminated
    Powerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-140BL
  • Z-0594-06 · Dec 14, 2005 · Terminated
    Powerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-135BL
  • Z-0593-06 · Dec 14, 2005 · Terminated
    Powerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-155BL
  • Z-0590-06 · Dec 14, 2005 · Terminated
    Powerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-155BL
  • Z-0589-06 · Dec 14, 2005 · Terminated
    Powerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-140BL
  • Z-0596-06 · Dec 14, 2005 · Terminated
    Powerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-155BL

…and 1 more.

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page